Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005639 |
YEM_ID: | YEM-856 |
ID: | TCMBANKHE005639/YEM-856 |
植物拉丁名: |
|
功能与主治: | To dispel wind and attack toxin, disperse swelling and relieve pain, anticancer (itself with high toxicity)./Nose carcinoma, eczema, neuralgia, wind-damp impediment pain, scab and lai , scrofula, clove sore, knocks and falls. |
药用植物名: | 钩吻|断肠草 |
药名: | 断肠草 |
来源: | 云南民族药物志：第五卷 |
药用部位: | whole herb |
使用民族: | 阿昌族/布朗族/傣族/德昂族/哈尼族/基诺族/景颇族/拉祜族/傈僳族/苗族/佤族/瑶族/壮族 |
TCM_ID_id: | 1610 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000197 | 6-methoxyginiposidicacid | C17H24O11 | |||
| TCMBANKIN000956 | 11-methoxygelsemamide | C21H25NO4 | CC=C1CN2C3CC(C2=O)(C4CC1C3CO4)C5=C(C=C(C=C5)O)COC | ||
| TCMBANKIN001160 | humantenirine | C21H26N2O4 | 370.4 g/mol | CC=C1CNC2CC3(C4CC1C2CO4)C5=C(C=C(C=C5)OC)N(C3=O)OC | |
| TCMBANKIN001340 | akuammidine n-oxide | akuammidinen-oxide | C21H24N2O4 | 368.4 g/mol | CC=C1C[N+]2(C3CC1C(C2CC4=C3NC5=CC=CC=C45)(CO)C(=O)OC)[O-] |
| TCMBANKIN003580 | koumine | C20H22N2O | 306.4 g/mol | CN1CC2(C3CC4C5=NC6=CC=CC=C6C52CC1C3CO4)C=C | |
| TCMBANKIN004456 | dihydromelilotoside | CHEMBL1087938; AC1NSUKW; 3-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]propanoic acid; Dihydromelilotoside; BDBM50310449 | C15H20O8 | 328.31 g/mol | C1=CC=C(C(=C1)CCC(=O)O)OC2C(C(C(C(O2)CO)O)O)O |
| TCMBANKIN004729 | 19-(z)-taberpsychine | C20H26N2O | CC=C1CN(CCC2=C(C3CC1CCO3)NC4=CC=CC=C24)C | ||
| TCMBANKIN005499 | humantenmine | C19H22N2O3 | 326.4 g/mol | CCC1=NC2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC | |
| TCMBANKIN007082 | 11-methoxyhumantenine | Humantenine, 11-methoxy-; 93914-74-0; N-Methylhumantenirine | C22H28N2O4 | 384.5 g/mol | CC=C1CN(C2CC3(C4CC1C2CO4)C5=C(C=C(C=C5)OC)N(C3=O)OC)C |
| TCMBANKIN007768 | 19-(r)-hydroxydihydrogelsemine | C20H24N2O3 | 340.4 g/mol | CC(C12CN(C3C1C4(C5CC2C3CO5)C6=CC=CC=C6NC4=O)C)O | |
| TCMBANKIN009210 | koumidine | CHEMBL477697; Koumidine; ZINC101620892 | C19H22N2O | 294.4 g/mol | CC=C1CN2C3CC1C(C2CC4=C3NC5=CC=CC=C45)CO |
| TCMBANKIN009438 | gelsevirine | C21H24N2O3 | 352.4 g/mol | CN1CC2(C3CC4C5(C2C1C3CO4)C6=CC=CC=C6N(C5=O)OC)C=C | |
| TCMBANKIN011296 | 7-hydroxydihydromatatabiether | C10H18O2 | CC1COC2(CCC1C2CO)C | ||
| TCMBANKIN011450 | 19-(z)-akuammidine | C21H24N2O3 | 352.4 g/mol | CC=C1CN2C3CC1C(C2CC4=C3NC5=CC=CC=C45)(CO)C(=O)OC | |
| TCMBANKIN012494 | 19-(r)-hydroxydihydrogelsevirine | C21H26N2O4 | 370.4 g/mol | CC(C12CN(C3C1C4(C5CC2C3CO5)C6=CC=CC=C6N(C4=O)OC)C)O | |
| TCMBANKIN012702 | 19-oxo-gelsenicine | C19H20N2O4 | CC(=O)C1=NC2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC | ||
| TCMBANKIN013339 | 20-hydroxydihydrorankinidine | C20H26N2O4 | 358.4 g/mol | CCC1(CNC2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC)O | |
| TCMBANKIN015137 | Hydroxygenkwanin | 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-chromen-4-one; ACon1_000842; MEGxp0_000798; AIDS-219930; AIDS219930; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-4-chromenone; hydroxygenkwanin; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxychromen-4-one; 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-chromone | C22H22O11 | 462.4 | COC1=CC(=C2C(=C1)OC(=CC2=O)C3=CC(=C(C=C3)O)O)O |
| TCMBANKIN016008 | humantenidine | C19H22N2O4 | 342.4 g/mol | CCC1=NC2CC3(C4C(C1C2CO4)O)C5=CC=CC=C5N(C3=O)OC | |
| TCMBANKIN016047 | 16-epi-voacarpine | C21H24N2O4 | 368.4 g/mol | CC=C1CN2C3CC4=C(C2(CC1C3(CO)C(=O)OC)O)NC5=CC=CC=C45 | |
| TCMBANKIN017406 | rankinidine | C20H24N2O3 | 340.4 g/mol | CC=C1CNC2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC | |
| TCMBANKIN018462 | dihydrokoumine | C20H24N2O | CN1CC2(C3CC4C5C2(CC1C3CO4)C6=CC=CC=C6N5)C=C | ||
| TCMBANKIN018697 | epiwilsonine | C20H25NO4 | 343.4 g/mol | COC1CC23C4=CC(=C(C=C4CCCN2CC5C3(O5)C=C1)OC)OC | |
| TCMBANKIN021010 | 14-hydroxygelsedine | C19H24N2O4 | 344.4 g/mol | CCC1C2C3COC(C2O)C4(CC3N1)C5=CC=CC=C5N(C4=O)OC | |
| TCMBANKIN021075 | humuladienone | C15H24O | 220.35 g/mol | CC1CC=CC(CC=C(CCC1=O)C)(C)C | |
| TCMBANKIN023956 | n-desmethoxyhumantenine | C20H24N2O2 | CC=C1CN(C2CC3(C4CC1C2CO4)C5=CC=CC=C5NC3=O)C | ||
| TCMBANKIN024471 | humantenine | C21H26N2O3 | 354.4 g/mol | CC=C1CN(C2CC3(C4CC1C2CO4)C5=CC=CC=C5N(C3=O)OC)C | |
| TCMBANKIN025087 | gelsemine | C20H22N2O2 | 322.4 g/mol | CN1CC2(C3CC4C5(C2C1C3CO4)C6=CC=CC=C6NC5=O)C=C | |
| TCMBANKIN026404 | koumine n-oxide | kouminen-oxide | C20H22N2O2 | 322.4 g/mol | C[N+]1(CC2(C3CC4C5=NC6=CC=CC=C6C52CC1C3CO4)C=C)[O-] |
| TCMBANKIN028717 | 7-hydroxy-6,8-dimethoxy coumarin | C11H10O5 | COC1=C(C(=C2C(=C1)C(=O)C=CO2)OC)O | ||
| TCMBANKIN029257 | ranol | C26H46O5 | 438.6 g/mol | CC(CCC(CCO)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C | |
| TCMBANKIN029477 | 11-Hydroxyrankinidine | Spiro(3H-indole-3,8'(7'H)-(4,7)methanooxepino(4,3-b)pyridin)-2(1H)-one, 3'-ethylidene-1',2',3',4',4'a,5',9',9'a-octahydro-6-hydroxy-1-methoxy-, (3S,3'Z,4'R,4'aS,7'R,9'aS)-; Humantenine, 4-demethyl-11-hydroxy-; 11-hydroxyrankinidine; (3'Z)-3'-ethylidene-6-hydroxy-1-methoxy-1',2',3',4',4a',5',9',9a'-octahydro-7'H-spiro[indole-3,8'-[4,7]methanooxepino[4,3-b]pyridin]-2(1H)-one; 122590-03-8; (7'Z)-7'-ETHYLIDENE-6-HYDROXY-1-METHOXY-11'-OXA-5'-AZASPIRO[INDOLE-3,2'-TRICYCLO[6.3.1.0?,?]DODECANE]-2-ONE; (7'Z)-7'-ETHYLIDENE-6-HYDROXY-1-METHOXY-11'-OXA-5'-AZASPIRO[INDOLE-3,2'-TRICYCLO[6.3.1.0?,?]DODECAN]-2-ONE; 9477AF; Nb-Demethyl-11-hydroxyhumantenine; BG01070136 | C20H24N2O4 | 356.4 g/mol | CC=C1CNC2CC3(C4CC1C2CO4)C5=C(C=C(C=C5)O)N(C3=O)OC |
| TCMBANKIN029508 | tabersonine | C21H25N2O2+ | 337.4 g/mol | CCC12CC(=C3C4(C1[NH+](CC4)CC=C2)C5=CC=CC=C5N3)C(=O)OC | |
| TCMBANKIN030906 | 11-methoxy-19-(r)-hydroxygelselegine | C21H28N2O6 | CC(C1(C2CC3C4(CC(C2CO3)N1)C5=C(C=C(C=C5)OC)N(C4=O)OC)CO)O | ||
| TCMBANKIN031806 | sempervirine(ii) | C19H16N2 | |||
| TCMBANKIN032255 | elegansamine | C29H36N2O6 | CC1CC(C2C1COC(=O)C2CC(C)C3=NC4CC5(C6CC3C4CO6)C7=CC=CC=C7N(C5=O)OC)O | ||
| TCMBANKIN032608 | des-o-methylicariin | C33H42O15 | CC1C(C(C(C(O1)OC2=C(CC3=C(C2=O)C(=CC(=C3CCC(C)(C)OC4C(C(C(C(O4)CO)O)O)O)O)O)C5=CC=C(C=C5)O)O)O)O | ||
| TCMBANKIN037031 | p-methoxyhydrocinnamic acid | C10H12O3 | 180.2 g/mol | COC1=CC=C(C=C1)CCC(=O)O | |
| TCMBANKIN037097 | 15-hydroxyhumantenine | C21H26N2O4 | 370.4 g/mol | CC=C1CN(C2CC3(C4CC1(C2CO4)O)C5=CC=CC=C5N(C3=O)OC)C | |
| TCMBANKIN039257 | 19-(r)-acetyldihydrogelseevirine | C23H28N2O5 | CC(C12CN(C3C1C4(C5CC2C3CO5)C6=CC=CC=C6N(C4=O)OC)C)OC(=O)C | ||
| TCMBANKIN040365 | 11-Hydroxyhumantenine | 370.4 g/mol | |||
| TCMBANKIN041198 | Gelsemoxonine | C19H22N2O5 | 358.388 | c1([H])c([H])c([C@]2(C([H])([H])[C@]([H])(N([H])[H])[C@]([H])(C([H])([H])O3)[C@@](C(=O)C([H])([H])C([H])([H])[H])(O4)[C@]4([H])[C@@]23[H])C(=O)N5OC([H])([H])[H])c5c([H])c1[H] | |
| TCMBANKIN042578 | Kudinoside A | kudinoside a | 927.1 g/mol | ||
| TCMBANKIN043600 | Gelsemamide | C20H24N2O3 | 340.416 | [C@]([H])(C([H])([H])[C@@]1(c2c(N([H])OC([H])([H])[H])c([H])c([H])c([H])c2[H])C3=O)([C@@]4([H])[C@]([H])(C([H])([H])[C@]1([H])OC4([H])[H])\C(=C([H])/C([H])([H])[H])\C5([H])[H])N35 | |
| TCMBANKIN043672 | Gelsemicine | C20H26N2O4 | 358.431 | O1C([H])([H])[C@@]([H])([C@@]([H])(C([H])([H])[C@@]12[H])[C@](C([H])([H])C([H])([H])[H])([H])N3[H])[C@]3([H])C([H])([H])[C@@]24C(=O)N(OC([H])([H])[H])c(c([H])c(OC([H])([H])[H])c([H])c5[H])c45 | |
| TCMBANKIN044597 | Gemin A | C82H56O52 | 1873.3 g/mol | c1(O[H])c(O[H])c([H])c(C(=O)OC([H])([H])[C@]2([H])[C@@]([H])(OC(=O)c(c([H])c(O[H])c(O[H])c3O[H])c34)[C@]5([H])[C@@]([H])(OC(=O)c6c(c(O[H])c(O[H])c(O[H])c6[H])c(c(O[H])c(O[H])c(O[H])c7[H])c7C(=O)O5)[C@ @]([H])(OC(=O)c8c([H])c(O[H])c(O[H])c(O[H])c8Oc9c(O[H])c(O[H])c([H])c(C(=O)O[C@]([H])([C@]([H])(OC(=O)c%10c(O[H])c(O[H])c(O[H])c([H])c%10[H])[C@@]([H])(OC(=O)c%11c([H])c(O[H])c(O[H])c(O[H])c%11[H])[C@ @]([H])([C@@]%12([H])C([H])([H])OC(=O)c(c([H])c(O[H])c(O[H])c%13O[H])c%13%14)OC(=O)c(c([H])c(O[H])c(O[H])c%15O[H])c%14%15)O%12)c9[H])O2)c4c1O[H] | |
| TCMBANKIN045011 | Gelselegine | C20H26N2O4 | 358.431 | c1([H])c([H])c([C@]2(C([H])([H])[C@@]([H])([C@]([H])(C([H])([H])O3)[C@]4([H])C([H])([H])[C@]23[H])N([H])[C@]4(C([H])([H])O[H])C([H])([H])C([H])([H])[H])C(=O)N5OC([H])([H])[H])c5c([H])c1[H] | |
| TCMBANKIN045080 | Gelsamydine | C29H36N2O6 | c1([H])c([H])c([C@]2(C([H])([H])[C@@]([H])([C@]([H])(C([H])([H])O3)[C@]4([H])C([H])([H])[C@]23[H])N=C4[C@]([H])(C([H])([H])[H])C([H])([H])[C@@]5([H])[C@]6([H])[C@@]([H])(C([H])([H])[C@]([H])(C([H])([H ])[H])[C@@]6([H])C([H])([H])O[H])OC5=O)C(=O)N7OC([H])([H])[H])c7c([H])c1[H] | ||
| TCMBANKIN046024 | 19-(r)-acetoxydihydrogelsevirine | C23H28N2O5 | |||
| TCMBANKIN046523 | gelsemine n-oxide | gelseminen-oxide | C20H22N2O3 | 338.4 | C[N+]1(CC2(C3CC4C5(C2C1C3CO4)C6=CC=CC=C6NC5=O)C=C)[O-] |
| TCMBANKIN047102 | gelsedine | C19H24N2O3 | 328.4 g/mol | CCC1C2CC3C4(CC(C2CO3)N1)C5=CC=CC=C5N(C4=O)OC | |
| TCMBANKIN047792 | N-Desmethoxyrankinidine | 310.4 g/mol | |||
| TCMBANKIN058687 | 12a-hydroxyrotenone | rotenolone,12α-hydroxyrotenone,12alpha-hudroxyrotenone | C23H22O7 | 410.4 g/mol | CC(=C)C1CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4(C3=O)O)OC)OC |
| TCMBANKIN058725 | 1-ethenyl-1-methy-2-(1-methylethenyl)-4-(methylethylldene)-cyclohexane | elixene;cyclohexane,1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-methylethylidene)-;elixen;gamma-elemene;.gamma.-Elemene | C15H24 | 204.35 g/mol | CC(=C1CCC(C(C1)C(=C)C)(C)C=C)C |
| TCMBANKIN059289 | 19-(r)-hydroxydihydrogelsevirine | 19-(s)-hydroxydihydrogelsevirine | C21H26N2O4 | 370.4 g/mol | CC(C12CN(C3C1C4(C5CC2C3CO5)C6=CC=CC=C6N(C4=O)OC)C)O |
| TCMBANKIN059290 | 19-(r)-hydroxydihydrogelsemine | 19-(r)-hydroxydihydrokoymine | C20H24N2O3 | 340.4 g/mol | CC(C12CN(C3C1C4(C5CC2C3CO5)C6=CC=CC=C6NC4=O)C)O |
| TCMBANKIN059291 | 19-(r)-hydroxydihydrokoumine | 19-(s)-hydroxydihydrokoumine | C20H24N2O2 | CC(C12CN(C3CC14C5=CC=CC=C5N=C4C6CC2C3CO6)C)O | |
| TCMBANKIN059408 | akuammidine n-oxide | C21H24N2O4 | 368.4 g/mol | CC=C1C[N+]2(C3CC1C(C2CC4=C3NC5=CC=CC=C45)(CO)C(=O)OC)[O-] | |
| TCMBANKIN059413 | 15-hydroxyhumantenine | C21H26N2O4 | 370.4 g/mol | CC=C1CN(C2CC3(C4CC1(C2CO4)O)C5=CC=CC=C5N(C3=O)OC)C | |
| TCMBANKIN059419 | n-desmethoxyrankinidine | C19H22N2O2 | 310.4 g/mol | CC=C1CNC2CC3(C4CC1C2CO4)C5=CC=CC=C5NC3=O | |
| TCMBANKIN061308 | gelsevirine | C21H24N2O3 | 352.4 g/mol | CN1CC2(C3CC4C5(C2C1C3CO4)C6=CC=CC=C6N(C5=O)OC)C=C | |
| TCMBANKIN061633 | 5-methoxy-7-(4''-hydroxy-3''-methoxy-phenyl)-1-phenyl-3-heptanone | C21H26O4 | COC1=C(C=CC(=C1)CCC(CC(=O)CCC2=CC=CC=C2)OC)O | ||
| TCMBANKIN061679 | Oxoglaucine | Noraporphin-7-one, 4,5,6,6a-tetradehydro-1,2,9,10-tetramethoxy-; oxoglaucine; MLS000574946; ZINC01726300; TNP00333; NCGC00142561-01; 7H-Dibenzo(de,g)quinolin-7-one, 1,2,9,10-tetramethoxy-; SMR000156317; O-Methylatheroline; NCGC00017383-01; ST057704; 7H-Dibenzo[de,g]quinolin-7-one, 1,2,9,10-tetramethoxy-; ATHEROLINE, O-METHYL; NSC141543; 5574-24-3; Liriodendron base | C20H17NO5 | 351.4 g/mol | COC1=C(C2=C3C(=C1)C=CN=C3C(=O)C4=CC(=C(C=C42)OC)OC)OC |
| TCMBANKIN061850 | p-methoxyhydrocinnamic acid | C10H12O3 | 180.2 g/mol | COC1=CC=C(C=C1)CCC(=O)O | |
| TCMBANKIN061920 | epiwilsonine | C20H25NO4 | 343.4 g/mol | COC1CC23C4=CC(=C(C=C4CCCN2CC5C3(O5)C=C1)OC)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab